RE:RE:RE:RE:RE:RE:RE:"The reality is the boats are shaking" FDA's Accelerated Approval process for innovative and novel drugs to treat rare and orphan diseases has moved in the direction of granting Accelerated Approval prior to having a Phase 3 clinical study in place and fully enrolled.